Stock Investment Reports-30th July

UPL, the only Indian play in the global generic crop protection space, has reported excellent performance for Q1 FY 2009. Read More...
FIL, 54% subsidiary of Schering Plough – USA, has reported subdued performance for Q2 CY 2008. Read More....
ScripScan-Research Reports
BSL, air-conditioning and commercial refrigeration major, has reported remarkable performance for Q1 FY 2009. It should be noted that BSL acquired Naseer Electricals (had turnover of Rs. 107 crore in FY 2007) w.e.f. January 24, 2008. Read More...


V.S.T. Tillers Tractors Ltd.-
Research Report Dated 29th July ...... Click Here to Read


Tamil Nadu Newsprint & Papers-Long Term Investment
High dividend yield, low valuations and a strong business model make Tamil Nadu Newsprint & Papers an attractive long-term investment bet Read More....



*** Newsletters in past : Stocks News & Views Newsletters ***
*** Value & Multibagger Stocks: http://stocks-information.blogspot.com ***

Tamil Nadu Newsprint & Papers-Long Term Investment

High dividend yield, low valuations and a strong business model make Tamil Nadu Newsprint & Papers an attractive long-term investment bet

TAMIL NADU Newsprint and Papers (TNPL) is one of the leading manufacturers of printing and writing paper and newsprint in India. The paper sector is one of the most fragmented industries in the country. The price of wood pulp — which is the raw material for making paper — is rising sharply, squeezing the margins of companies. Environmental laws prevent forestation on degraded land. This prevents paper companies from attaining self-sufficiency in raw materials. Moreover, the production of bamboo — another raw material for manufacturing paper — has fallen sharply, thereby pushing up its prices. In addition, almost all large players are in expansion mode, adding and seeking new sources of raw materials.

The state government-promoted paper major, TNPL, was one of the first to initiate major capacity expansion in this industry. In the past three years, the company has spent nearly Rs 500 crore to increase its capacity. Going forward, TNPL plans to hike its capacity by another 70% to nearly 400,000 tonnes per annum by FY10.

BUSINESS:
The company’s business model is unique as it manufacturers paper from bagasse, which is the waste from production of sugar. It has an arrangement with sugar mills in Tamil Nadu for procurement of bagasse. This insulates TNPL from the fluctuations in prices of wood pulp.
For procurement of wood, the company has entered into a long-term agreement with Tamil Nadu Forest Plantation Corp. To meet its future raw material requirements, the company has set up a captive plantation. This backward integration has helped TNPL to become selfsufficient in raw materials, unlike many of its large competitors. The company also uses waste heat and baggase to produce enough power to meet its entire requirement.


TNPL has strategically changed its product mix over the past 7-8 years to match the market requirements. For instance, in FY01, newsprint constituted 33% of the company’s total production, while in FY07, newsprint accounted for only 1% of its total production.The demand for paper is increasing at a similar rate as the economy. As the level of industrialisation and education increases, the per capita consumption of paper is also set to increase in the country. The ongoing capacity expansion by domestic paper manufacturers is unlikely to hurt prices due to rising domestic consumption and exports. This bodes well for companies like TNPL.

FINANCIALS:
Financially, the company is one of the best-managed paper companies in the country. Its sales have been on a secular upside as TNPL has been able to change its product mix. The company’s sales and net profit have registered a compound annual growth rate (CAGR) of 13.6% and 20.1%, respectively, in the past four years. These growth rates are higher than that of other paper companies. The company’s EBITDA (earning before interest, depreciation, tax and amortisation) margin improved to 23.8% in FY08 from 16.7% in FY04, on the back of improved product mix and cost-containment measures.


TNPL has been successful in reducing the cost of its debt by swapping costlier debt with cheaper one. This is evident as its interest expense was more than Rs 50 crore in FY00, while it stood at less than Rs 25 crore in FY08. Moreover, the company has consistently paid dividends. In the past three years, TNPL’s dividend payout has witnessed a CAGR of 18%. Its current dividend yield is close to 5%. As profit growth is expected to remain strong in future, the company’s dividend payouts are also likely to follow suit.

VALUATIONS:
The stock is trading at a price-to-earnings (P/E) multiple of only 5.5, which is almost equal to the average P/E of domestic paper manufacturers. The company’s return on capital employed (RoCE) is in line with that of its peers. However, its consistency in sales growth, profit growth and RoCE is far better than that of its competitors. TNPL’s dividend yield is also the highest in the industry. All these factors make it an interesting long-term bet for investors.

MAKING THE WRITE CHOICE
Tamil Nadu Newsprint and Papers (TNPL) has spent nearly Rs 500 crore to increase its capacity in the past three years

It plans to hike its capacity by another 70% to nearly 400,000 tonnes per annum by FY10

The company’s business model is unique as it manufacturers paper from bagasse, which is the waste from production of sugar

Backward integration has helped TNPL to become self-sufficient in raw materials, unlike many of its large competitors

The company’s sales and net profit have registered a CAGR of 13.6% and 20.1%, respectively, in the past four years, which are higher than that of its peers

TNPL is one of the most widely held stocks in the paper industry

Institutional investors like Goldman Sachs and Templeton India Equity fund hold stake in the company

Bull's Eye-ULTRATECH CEMENT,ABAN OFFSHORE,SESA GOA,SASKEN COMMUNICATION,LARSEN & TOUBRO,BHEL

BHARAT HEAVY ELECTRICALS
RESEARCH: HSBC
RATING: OVERWEIGHT
CMP: RS 1,654.90

HSBC maintains ‘overweight’ rating on Bharat Heavy Electricals (Bhel) with a target price of Rs 2,300. The recent correction in the stock price provides a buying opportunity as fundamentals remain intact. The share price does not reflect the growth momentum of the domestic power equipment market. India aims to add 78 GW of capacity in the 11th Five-Year Plan, and Bhel, with a 65% market share, is its main beneficiary. Strong new order inflow of Rs 14,500 crore resulted in a Rs 95,000-crore order backlog.

The gas turbine and railway locomotive businesses are additional growth drivers. Bhel has formed three JVs with state utilities to set up supercritical projects. HSBC maintains its revenue growth estimate of 27% for FY09E, given that Bhel has expanded its capacity and has been able to address its execution-related issues. But higher commodity prices and staff cost provisioning may impact the company’s profitability, thus affecting EBITDA margins by 200 bps in FY09E and FY10E, lowering profit growth by 8-10%. HSBC expects Bhel to report EPS of Rs 79.3 and Rs 103.1 in FY09E and FY10E, respectively.

LARSEN & TOUBRO
RESEARCH: DEUTSCHE BANK
RATING: SELL
CMP: RS 2,625.60
DEUTSCHE Bank has downgraded Larsen & Toubro (L&T) to ‘sell’ with a revised target price of Rs 2,000 (-18%). Despite underperforming the Sensex by 6% YTD, L&T trades at 21x FY09E and 16x FY10E P/E, which seems high in the current market downturn. Deutsche Bank has cut its earnings estimates by 8% for FY09E and 12% for FY10E. Its concerns are:
(1) risks to 44% of the order book in steel, oil & gas and real estate;
(2) turnaround of international subsidiaries keeps getting pushed back; and
(3) the quality of earnings may deteriorate as the working capital cycle stretches.

Also Read: Best Indian stock pick: Larsen and Toubro

L&T has seen significant order inflows in the power, construction, real estate and steel sectors. Earnings growth momentum picked up in FY08, albeit from a low base in FY07. However, the risk profile for steel, power and real estate sectors has increased significantly, and can impact the company’s medium-term growth prospects. While the revised estimates are largely in line with consensus, operating free cash flows may be hit as order inflow momentum slows down.

SASKEN COMMUNICATION TECH
RESEARCH: MERRILL LYNCH
RATING: UNDERPERFORM
CMP: RS 154.40
Merrill Lynch has cut the target price of Sasken Communication Technologies by 7% to Rs 140 and has retained ‘underperform’ rating on the stock. Merrill Lynch has cut its FY09 and FY10 earnings estimates by 6% and 10%, respectively, to factor in sluggish Q1 revenue growth and muted Q2 revenue guidance in Sasken’s IT services business. High attrition levels at 29% and potentially weak Q2 results remain cause for concern. The management has indicated that revenue growth in IT services can reduce to 17-20% y-o-y from 25-29% earlier. IT services revenues grew by 7.5% q-o-q — 1% lower than estimates — with EBITDA margins rising by 305 bps, driven by the rupee’s depreciation. Employee numbers fell and the management scaled down net hiring numbers from 700 to 500 for the year. Sasken’s products business grew 112% y-o-y, though 60% came from customisation revenues and can be volatile. With a weak Q2 ahead and growth likely to be back-ended, the stock can languish at current levels.

SESA GOA
RESEARCH: MORGAN STANLEY
RATING: OVERWEIGHT
CMP: RS 3,101.45

MORGAN Stanley maintains ‘overweight’ rating on the stock due to constructive stance on iron ore pricing and confidence in Sesa Goa’s ability to deliver robust volume growth over the next two years. Sesa Goa announced Q1 PAT of Rs 636 crore, up 436% y-o-y. EBITDA was Rs 800 crore, 39% ahead of estimates, due to higher volumes and better realisations. Iron ore sales volumes were strong, at 3.2 mt, up 48% y-o-y, against the expectation of 18% increase. This should put Sesa Goa on track to achieve its annual target of 25-30% annual growth. Iron ore realisation was also ahead of estimates at Rs 3,400/tonne — a rise of 11% q-o-q and 92% y-o-y. This was mainly due to continued strength in spot prices, favourable rupee movement and 65% y-o-y increase in the contract settlement price. For the rest of FY09, Sesa Goa should realise the benefit of 81-97% increase in contract settlement price of iron ore. Sesa Goa’s coke realisations were strong at Rs 21,000/tonne, up 42% q-o-q, driving the 8% q-o-q growth in coke EBIT. The company’s EBITDA margin was a healthy 62% in Q1. Though this was 2,550 bps higher y-o-y, it was 850 bps down sequentially, because of higher transportation costs. This was due to higher proportion of sales from Orissa and Karnataka, and increased trucking and rail charges.

ABAN OFFSHORE
RESEARCH: GOLDMAN SACHS
RATING: BUY
CMP: RS 2,695.15
GOLDMAN Sachs reiterates ‘buy’ rating on Aban Offshore with a P/E-based 12-month target price of Rs 4,375, implying potential upside of 64%. Discounted cash flow value is Rs 4,500/share. Aban’s FY08 pre-exceptional consolidated net profit stood at Rs 310 crore, beating the estimate of Rs 250 crore by 22%. Aban’s reported FY08 profit of Rs 120 crore had a one-time translation loss of Rs 180 crore due to adverse movement of NOK-USD exchange rates since March ’07. Strong operating results were offset by higherthan-expected interest cost. Better-than-expected operating results and persistent market fears of large derivatives loss proving to be untrue will lead to re-rating of the stock. Goldman expects Aban to announce contracts for five assets — jack-up rigs Deep Driller III, VI, VII and VIII and semi-submersible rig Aban Pearl — over the next 1-6 months. Goldman estimates the jack-up day rates to be $180-185K for short-term contracts and at a 10% discount for long-term contracts. For Aban Pearl, Goldman has assumed a day rate of $275K. So far, Aban’s last nine contracts have been at rates higher than estimates. Aban’s stock is trading at 5.8x FY10E EPS, which implies a discount of 23% to the global average for offshore drilling companies. Aban still has the best earnings growth profile in the medium term in its peer group, with EPS CAGR of 162% between FY08 and FY10E, even after cutting FY09E EPS by 3.5% to reflect delay in deployment of Frontier Ice at higher day rates.

ULTRATECH CEMENT
RESEARCH: INDIABULLS SECURITIES
RATING: HOLD
CMP: RS 550.50

INDIABULLS Securities reiterates ‘hold’ rating on UltraTech Cement. A slowdown in construction activity in the real estate sector is expected to adversely affect cement sales. However, ongoing infrastructure-related construction activities should protect volume growth from declining sharply. Going forward, Indiabulls expects that the company’s new capacity addition in South India, along with strong demand in the region, will help cement sales volume to witness a CAGR of 13% in the next two years to reach 19.2 mt in FY10E. During the quarter, EBITDA margin fell 239 bps y-o-y due to rise in raw material and fuel costs. Realisation rate has also started moderating — it increased a mere 1% q-o-q in Q1 FY09, lower than the 3% q-o-q increase in Q4 FY08. Excess cement supply projected in FY09E and the government’s price control policies may further reduce realisation rate. Indiabulls believes that escalating costs and moderating realisations will continue to keep UltraTech’s margins under pressure in coming quarters.

United Phosphorus (UPL)-Stock Investment report

Report Date: July 26, 2008
Company Name: United Phosphorus (UPL)
Recommendation: BUY
CMP – Rs. 336.95

Target Price – Rs. 425/-
Mkt. Cap. Rs. 7,401.1 crore

Investment Rationale
Ø UPL, the only Indian play in the global generic crop protection space, has reported excellent performance for Q1 FY 2009. Consolidated Net Sales soared up by 54.3% to Rs. 1299.31 crore led by 40% volume growth (owing to robust demand from farmers as farm produce prices have gone up significantly) and balance was value growth. This was because Raw material prices have been going up and company has been passing on a lot of this to customers. While domestic revenues jumped by 76% to Rs. 286 crore (Rs. 163 crore), exports (contributing 78%
of revenues) grew @ 51% to Rs. 1,028 crore (Rs. 683 crore).
Despite impressive topline growth, OPM% declined slightly to 19.3%, mainly because of high raw material costs, which continues to be a cause for concern for the rest of the year as well. Sharp rise in Other income of Rs. 14.74 crore (as company had cash balance of Rs. 150-200 crore) was more than negated by almost doubled finance cost of Rs. 63.43 crore (includes FE loss of Rs 22.94 crore arising on revaluation of outstanding foreign currency borrowings & advances as against FE gain of Rs 34.66 crore). Depreciation declined by 25.2% to Rs. 37.76 crore
(as amortisation has come down on account of merger). In nutshell, PBT shot up by 88.5% to Rs. 164.47 crore. Lower average tax rate of 11.6% further led to doubling of PAT to Rs. 147.67 crore.
Ø UPL is the leading Indian agrochemical player and among the top three generic players globally in this industry. It is engaged in research, manufacture and distribution of agrochemicals and specialty chemicals worldwide. It also has presence in seeds space through 49% stake in Advanta, which could emerge as key growth & valuation driver over long term.

Ø Company has built strong presence in highly consolidated market with high entry barriers through series of strategic acquisitions (Evofarms – Columbia, Icona – Argentina, Cerexagri, Europe, etc.) in niche markets across the globe. Through acquisitions, strategic alliances and network of subsidiaries, UPL has built marketing network across the globe and its international revenues account for > 78% of its total revenue. It exports to over 100 countries, primary markets being Europe and North America with high expectations of growth in Latin America.

Ø Agricultural scenario in India and abroad has reached very crucial stage. Increasing shortfall of key food & commercial crops, rising pressure to step up farm productivity (Indian yield of most crops are far below global averages) and economics of adopting high yielding seed varieties for the farmer are demand drivers for high yielding seeds and agro chemicals. UPL, being leading agrochemical player, is set to grab the maximum share of this growing market.

Ø UPL’s longer term prospects appear bright in view of positive outlook on crop protection sector, potential synergies from Cerexagri acquisition as well as scale up of international registrations. Besides, company’s growing cash flows gives it ability to step up growth initiatives – both organic (plans to spend Rs. 2.6-3 billion in two years on increasing plant capacity and registrations) and inorganic.

Valuation
Ø At CMP, the share (Rs.2/-) is trading at 15.4 times FY 2009 expected consolidated EPS of Rs. 21.9 and 8 times FY 2010 expected consolidated EPS of Rs. 41.9. In view of excellent future prospects, we recommend to BUY the share at CMP.

Fulford India (FIL)-Research Report

Report Date: July 28, 2008.
Company Name: Fulford India (FIL)
Recommendation: BUY
CMP – Rs. 445/-
Target Price – Rs.600/-
Mkt. Cap. Rs. 174 crore

Investment Rationale
Ø FIL, 54% subsidiary of Schering Plough – USA, has reported subdued performance for Q2 CY 2008. Net sales grew @ 10% to Rs.51.54 crore. There has been decline in OPM% to 18% (23.7%) with sharp increase in raw material costs. As company imports major portion of its raw materials (~83%), weakening of the rupee has impacted input costs adversely. Moreover, there has been increase in input costs as China has closed down many of its chemical units for environment reasons. Company is unable to pass on raw material cost increase to its customers as existing price control laws limit companies from increasing prices of drug beyond 10% in 12 months. Staff cost has also increased with increase in its sales force to ramp up operations. Consequently, PBT
declined by 10.8% to Rs.10.82 crore and PAT declined by 10.1% to Rs.7.07 crore.

Ø During H1 CY08, Net sales were up by 7.6% to Rs.82.91 crore. OPM% declined to 10.7%. Consequently, PAT was lower at Rs.7.47 crore.

Ø FIL is present in therapeutic segments of Dermatology, Allergy & Respiratory, Anti-infective, Hepatitis, Rheumatology, Onclology and Cardiovascular. Company continues to explore all opportunities to strengthen existing product portfolio either thru own (parent’s) R&D pipeline or thru in-licensing options of non-Schering Plough products to extend the product range. During CY07, company launched two new products Alaspan Syrup and Alaspan AM. Both these new launches have been well received. Company is planning to launch two new products in CY 2008 – Feracrylum (wound healing agent) and Elocon (dermatology).

Ø Company is in process of developing strategic plans covering investment in growth and expansion. FIL aims to drive top-line growth aggressively thru new product launches, investing in brand building and growing existing products aggressively. It is also strengthening its sales & marketing team. All these efforts will call for investment and company has surplus cash (Rs 83 crore on Dec 31, 2007) which can be used for this purpose.

Ø Schering Plough Corp. has acquired Organon Bio-science and Organon has good presence in India thru its unlisted fully owned subsidiary– Organon (India). It is similar in size as Fulford India and has products for women’s health, etc. FIL is looking at opportunities for synergies of operations between these two companies.

Ø Parent company had upped its holding in FIL from 40% to 53.93%. Increasing commitment of the parent is indicative of likely larger involvement of Fulford India in global scheme of things.

Ø Indian pharma industry has been growing @ CAGR of 12% (+) in last 2-3 years. Going forward, prospects of the industry is good in view of increasing levels of income of people who then pursue better healthcare products and services, better access to healthcare facilities and Private insurance companies offering medical reimbursement products. Moreover, drug industry has submitted a proposal to the government to reverse the cap on price hike
for drugs outside price control from 10% to earlier 20%. Government is considering liberalizing this 10% mandatory cap on price hike. If the cap is liberalized, margins of pharma companies will improve.

Valuation
Ø FIL’s top-line will grow at CAGR of ~14% p.a. over next few years with launch of new products and operating leverage will help to improve profitability.

Ø Fulford is a cash rich company with surplus cash on hand @ Rs. 200/- (+) per share. At CMP, the share is trading at 8 times CY 2008 expected EPS of Rs. 55.9 and 6.5 times CY 2009 expected EPS of Rs. 68.2/-. Long term prospects of the company appear bright. We recommend to “BUY” at CMP.

Source: Geojit Members Research Desk

Blue Star Ltd. (BSL) - Investment research report

Report Date: July 29, 2008
Company Name: Blue Star Ltd. (BSL)
Recommendation: BUY
CMP – Rs. 368/-
Target Price – Rs. 500/-
Mkt. Cap. - Rs. 3,310.2 crore

Investment Rationale
Ø BSL, air-conditioning and commercial refrigeration major, has reported remarkable performance for Q1 FY 2009. It should be noted that BSL acquired Naseer Electricals (had turnover of Rs. 107 crore in FY 2007) w.e.f. January 24, 2008. Q1 FY 2009 result includes performance of Naseer and hence, figures are not strictly comparable. Net Sales grew @ 36.5% to Rs. 630.89 crore on back of excellent growth in main business segments. Central Air-
Conditioning Systems (CAC) sales grew @ 37.2% to Rs. 380.01 crore and Cooling Products business turnover grew @ 36.4% to Rs. 215.93 crore; while Professional Electronic sales rose @ 29.8% to Rs. 34.95 crore. OPM% enhanced to 9%, mainly due to decline in RM cost. PBIT% of CAC improved to 11.3% (10.2%), while PBIT% of Cooling Products business grew to 12.8% (10.4%). However, PBIT% of Professional Electronics declined to 15.2% (18.2%). Strong sales growth, improved margin coupled with substantially higher other income of Rs. 1.65 crore,
led to 65.9% spurt in PBT (before extra ordinary income) of Rs. 51.04 crore. PAT shot up by 63.2% to Rs. 36.42 crore. Pending order book as on June 30, 2008 grew @ 43% to Rs. 1410 crore (Rs. 983 crore on June 30, 2007).

Ø BSL is market leader in India in institutional and commercial users for refrigeration and CAC solutions. CAC segment is expected to be the biggest growth driver for BSL over next few years. Company is expected to be benefited immensely on account of growing investments in commercial construction and real estate market. It also enjoys preferred vendor status (owing to its end-to-end solutions offering as manufacturer, contractor and aftersales service provider) and this could lead to good repeat business. Key growth drivers for this segment would be
growing presence of organised retail chains, branded eateries, malls, multiplexes, IT & ITeS setups, telecom, power generation, healthcare and hospitality.

Ø Blue Star is India's first and only manufacturer of VRF systems and company is confident of gaining substantial market share in this high technology product category. Its foray into electrical contracting business also provides it with good opportunity to cross-sell electrical services to its existing HVAC customers.

Ø In cooling product business, focus will be on corporate, commercial and light commercial segments where BSL’s market share is now in double digits. Market shift in preference for split air-conditioners vis-a-vis window airconditioners has provided tremendous boost for this business. Company also made inroads into eateries segment with its new range of gelato dispensing machines and vertical showcases from ISA, Italy. In addition to agricultural
& horticultural, BSL offers cold storage solutions for hospitality, healthcare, pharma and dairy segments as well.

Ø Outlook for Professional Electronics and Industrial Systems business continues to be attractive. Its growth pattern in the last few years has been solid and its strong reputation as a value added reseller and system integrator will help it to further enhance market share.

Ø Installed population of air-conditioning and refrigeration equipment has been growing rapidly in recent times creating faster growth opportunities for after-sales service. BSL, being the largest after-sales service provider in the country, is well placed to grab the maximum share of this growing pie.

Valuation
Ø At CMP, share (Rs. 2/- paid up) is trading 14.9 times FY 2009 expected EPS of Rs. 24.7 and 10.4 times FY 2010 expected EPS of Rs. 35.3.

Ø In view of excellent future prospects in all business segments, topline is expected to grow @ ~ 25-30%. Cost control initiatives, value engineering and value added services would improve the profitability. As a result, bottomline would grow at higher rate than that of topline. Hence, we recommend to “BUY” the share from long term perspective.

Source: Geojit Members Research Desk

V.S.T. Tillers Tractors Ltd.-Investment Research Report

Report Date: July 29, 2008.
Company Name: V.S.T. Tillers Tractors Ltd.
Recommendation: BUY
CMP – Rs. 140
Target Price – Rs. 210/-
Mkt. Cap. Rs. 80.61 crore


Investment Rationale
Ø VST, Bangalore based farm equipment manufacturer of Power Tiller and low HP tractors, has come out withencouraging performance for Q1 FY09. Net Sales increased by 57.9% to Rs.59.40 crore. However, OPM% declined to 10.4% (11.5%). There was sharp rise in raw material cost to 70.3% (65.7%) of Net Sales, however operational efficiencies restricted fall in margins. Higher Sales aided by higher other income led to 63.8% spurt in PBT to Rs.6.37 crore and 54.6% rise in PAT to Rs.3.85 crore.

Ø Company has a technological tie-up with Mitsubishi Heavy Industries, which holds 3.78% stake in the country.

Ø VST is a leading player in the Power Tiller industry. The growth of tiller industry is dependant on availability of Government Subsidies and Bank Finance to small farmers. Due to overnment’s focus on agriculture, demand forpower tillers will be on a high. To tap lower-end tiller market and to accelerate sales, company has been importing Chinese Power Tillers in completely knocked down (CKD) form, assembling them and marketing under the brand name “ Dragon Shakti”. Along with this, company offers its own indigenously designed products with a longer
lifespan on the same platform.

Ø In Tractors, VST makes 18.5 HP tractors which are compact in size and cheaper than normal tractor. These tractors are also better than normal tractors and gives better results for farming. Company plans to aggressively market these tractors. Its Precision Components Division at Mysore produces the components, 40% of production is used for captive use in Power tillers and balance 60% is for catering to export market.

Ø Company has formed a JV with Mitsubishi, Japan to manufacture a range of multi diesel engines up to 50 HP for varied applications. VST will be holding 10% stake and balance 90% to be held by Mitsubishi. Technology and finance will be provided by Mitsubishi, Japan, while strategy and planning, marketing and day to day affairs will be handled by VST. Capex of Rs 41 Cr to be incurred for 30,000 units of small diesel engines plant at Mysore

Ø Market for power tillers and tractors is expected to grow steadily with Government’s focus on agriculture, easier and cheaper availability of credit, growth in organised retail in food products and revival of monsoon. Company is all set to exploit emerging opportunities and maintain its leadership position. Investments are being planned to upgrade technological capabilities and create additional capacity and attention is currently focused on strategies that would help further reinforce company’s market share by expanding dealer network.

Valuation
Ø At CMP, stock is trading 4 times FY 2009 expected EPS of Rs. 35 and 3.2 times FY 2010 expected EPS of Rs.43.

Hence, we recommend to “Buy” the share at CMP.
Source: Geojit Members Research Desk

Loan ???

A loan is a type of debt. This article focuses exclusively on monetary loans, although, in practice, any material object might be lent. Like all debt instruments, a loan entails the redistribution of financial assets over time, between the lender and the borrower.

The borrower initially does receive an amount of money from the lender, which they pay back, usually but not always in regular installments, to the lender. This service is generally provided at a cost, referred to as interest on the debt. A loan is of the annuity type if the amount paid periodically (for paying off and interest together) is fixed.

A borrower may be subject to certain restrictions known as loan covenants under the terms of the loan.

Acting as a provider of loans is one of the principal tasks for financial institutions. For other institutions, issuing of debt contracts such as bondsis a typical source of funding. Bank loans and credit are one way to increase the money supply.

Legally, a loan is a contractual promise of a debtor to repay a sum of money in exchange for the promise of a creditor to give another sum of money.

Secured
A secured loan is a loan in which the borrower pledges some asset (e.g. a car or property) as collateral for the loan.

A mortgage loan is a very common type of debt instrument, used by many individuals to purchase housing. In this arrangement, the money is used to purchase the property. The financial institution, however, is given security — a lien on the title to the house — until the mortgage is paid off in full. If the borrower defaults on the loan, the bank would have the legal right to repossess the house and sell it, to recover sums owing to it.

In some instances, a loan taken out to purchase a new or used car may be secured by the car, in much the same way as a mortgage is secured by housing. The duration of the loan period is considerably shorter — often corresponding to the useful life of the car. There are two types of auto loans, direct and indirect. A direct auto loan is where a bank gives the loan directly to a consumer. An indirect auto loan is where a car dealership acts as an intermediary between the bank or financial institution and the consumer.

A type of loan especially used in limited partnership agreements is the recourse note.
A stock hedge loan is a special type of securities lending whereby the stock of a borrower is hedged by the lender against loss, using options or other hedging strategies to reduce lender risk.

Unsecured
Unsecured loans are monetary loans that are not secured against the borrowers assets. These may be available from financial institutions under many different guises or marketing packages:
credit card debt
personal loans
bank overdrafts
credit facilities or lines of credit
corporate bonds

The interest rates applicable to these different forms may vary depending on the lender and the borrower. These may or may not be regulated by law. In the United Kingdom, when applied to individuals, these may come under the Consumer Credit Act 1974.

Multibaggers/ScripScan-24th July


 
 
 
Unitech is one of the Great Multibagger stock in the past. Right now Little bulls are started kicking up in this counter. As AT&T, the US telecom giant, Qatar Telecom and west Asia based telecom major Etisalat are finally shortlisted as the three bidders. Read More...
 
 
Indiabulls since its ipo over the last 4 years has been a 50 bagger.Whatever the group touched transformed into gold.You name it brokerage,real estate,consumer finance.Now it plans to be the leader in the retail sector.With the dynamic and aggresive management am sure they would be able to satiate the desires.  Read More....
 
 
 
 
Axis Bank was the first of the new private banks to have begun operations in 1994, after the Government of India allowed new private banks to be established. The largest and one of the best known Financial Institutions of the country, UTI has promoted Axis Bank. Read More...
 
 
Research Report Dated 23rd July ...... Click Here to Read

 

Newsletters in past : Stocks News & Views Newsletters

Multibaggers/ScripScan-24th July

 
 
 
Unitech is one of the Great Multibagger stock in the past. Right now Little bulls are started kicking up in this counter. As AT&T, the US telecom giant, Qatar Telecom and west Asia based telecom major Etisalat are finally shortlisted as the three bidders. Read More...
 
 
Indiabulls since its ipo over the last 4 years has been a 50 bagger.Whatever the group touched transformed into gold.You name it brokerage,real estate,consumer finance.Now it plans to be the leader in the retail sector.With the dynamic and aggresive management am sure they would be able to satiate the desires.  Read More....
 
 
 
 
Axis Bank was the first of the new private banks to have begun operations in 1994, after the Government of India allowed new private banks to be established. The largest and one of the best known Financial Institutions of the country, UTI has promoted Axis Bank. Read More...
 
 
Research Report Dated 23rd July ...... Click Here to Read

 

Newsletters in past : Stocks News & Views Newsletters

MultiBagger Stock:Axis Bank

Company Profile:
Axis Bank was the first of the new private banks to have begun operations in 1994, after the Government of India allowed new private banks to be established. The largest and one of the best known Financial Institutions of the country, UTI has promoted Axis Bank. The Bank's Registered Office is at Ahmedabad and its Central Office is located at Mumbai. Presently, the Bank has a very wide network of branches and it has one of the largest ATM networks in the country. The Bank has strengths in both retail and corporate banking and is one of the most technology driven banks in the country.

Financial Position:
For the first quarter of the FY'09 (ending 30th June, 2008), Axis Bank reported a stellar set of numbers with the net income growing up by 81.9% at Rs 1435.2 crore and the net profit registered a growth of 89% yoy to Rs 330 crore (including depreciation on bank's investment portfolio of Rs 225.2 crore) compared with Q1FY08.

This is excellent growth by any standards and we expect this momentum to continue in the next few years. Its NII (Net Interest Income) grew by 93% yoy in the current quarter to Rs 810, due to credit growth and improvement in NIMs (Net Interest Margins). On a sequential basis there has been a decline in the NIMs mainly on account of rising cost of funds and lower proportion of demand deposits in Q1 as compared to the last quarter. Asset growth has been strong across all the broad segments including retail, corporate and SMEs. Retail assets have grown by 52% yoy to Rs 14,638 crore, which constitutes 59% of the housing loan. The total net advances grew by 48% yoy to Rs 61,160 crore. The demand deposits constitute 40% of total deposits. The fee income during the quarter has grown by 80% to Rs 484 crore, particularly in the capital markets and corporate banking. Trading income has also grown during the quarter amounting to Rs 52.78 crore. Total investments have grown by 34% yoy r ising to Rs 35,718 crore. Axis Bank has witnessed a sharp increase in NPAs (Non performing Assets) as the net NPAs% has grown from 0.36 in Q4FY08 to 0.47 in Q1FY09.

Investment Positives:
Rapid growth in the bank's core business.
In the current quarterly report Axis Bank has shown great strength with increase in NIIs, net advances and fee income.
A dominant player in handling debt issues.
Axis bank has a wide network. It has added another 42 branches and extension counters and 140 ATMs during the quarter making the total to 713 branches and 2,904 ATMs. It has increased its coverage covering 433 centers.
Progressive globalization and achieving international standards.
Axis Bank adopts Misys tech to support growth in derivatives and boost risk management.

Concerns:
NPAs are growing. But its level of NPAs is below 1 %.Also among the new private banks Axis has the least exposure to the retail segment and this cushions against the bad debts.

Risk associated with the financial sector due to increase in the rate of interest. This is a real threat but the results for this quarter are still excellent considering that we saw the worst interest rate scenario in the last few months. Going forward we expect interest rate to soften.

Valuation:
Axis Bank has shown a strong growth in income and profits during a period which has been tough for all financials. The Bank is expected to have an EPS of around Rs 40 per share for FY09. At CMP of Rs 697.60, it trades at a P/E of over 15.75, which is very attractive. The PEG ratio ( PE/growth in NP) comes to a mere 0.18 which shows good scope for appreciation. The stock has corrected appreciably from the high of Rs 1150 earlier this year. We recommend stock as an excellent investment in the beaten down financial space with a target price of Rs 900.

Investment Idea - Elantas Beck India Limited (EBIL)

Report Date: July 23, 2008
Company Name: Elantas Beck India Limited (EBIL)
Recommendation: BUY
CMP – Rs. 241.30
Target Price – Rs. 310/-
Mkt. Cap. Rs. 191.3 crore

Investment Rationale
Ø EBIL, 88.55% subsidiary of Elantas Gmbh (electrical insulation division of 1.4 billion Euro Altana group), has reported decent performance for Q2 CY 2008. Net Sales increased by 15.1% to Rs. 49.38 crore led by 18.3% increase in sales of Electrical insulation business of Rs. 41.86 crore (Rs. 35.4 crore). Engineering & Electronic Resins and Material turnover remained stagnant at Rs. 7.9 crore. OPM% improved to 16.3%. Consequently, PBT rose by 24% to Rs. 8.67 crore and PAT by 29.1% to Rs. 5.85 crore.

Ø H1 CY 2008 performance was affected by slowdown witnessed by the company in Q1 CY 2008. Net Sales grew @ 7.8% to Rs. 93.81 crore. OPM% enhanced to 16.5%. As a result, PBT increased by 8.4% to Rs. 16.25 crore and PAT to Rs. 10.82 crore, growth of 6.5%.

Ø EBIL manufacture wide range of electrical insulation material and epoxy & polyurethane resins based construction chemicals.

Ø Increasing requirement of power by India’s growing economy is far in excess of supply. Augmentation of India’s power generation capacity with significant private sector participation and reforms of the power sector is a key focus of the government, which augur well for electrical equipment industry, ensuring sustained growth in demand for EBIL’s electrical insulation business.

Ø In view of optimistic outlook for electrical insulation business, company continues to plan for increasing volume of sales. Key projects have been initiated to enhance capacities and modernize production processes. Besides, acquisition of electrical insulation business of Sanmar Specialty Chemicals has improved company’s market position in secondary insulation systems.

Ø In order to better serve electrical industry, company has commissioned new laboratory for testing of electrical equipment and components, for certification on behalf of Underwriters Laboratory of USA standards. This laboratory is autonomous of company, but will provide intangible benefits to the company.

Ø Application of chemicals in civil construction and repair of civil structure is relatively new in India, particularly in Industrial building and infrastructure construction such as dams & bridges. Construction chemical is therefore rapidly growing sector. EBIL is firmly entrenched as a key player in niche areas of high and industrial floorings for auto, pharma and electronics / electrical sectors. During CY 2007, company introduced water-based acrylic / polyurethane wall coating products for both exterior and interior applications.

Ø Thus, EBIL, with its R&D capabilities, access to global technologies and innovation skills in technical & application areas, is all set to explore emerging opportunities in growing markets.
Valuation

Ø At CMP, the share (Rs. 10/- paid up) is trading at 8 times CY 2008 expected EPS of Rs. 30/- and 6.4 times CY 2009 expected EPS of Rs. 37.50. In view of bright future prospects, we recommend to “BUY” the share at CMP.

Unitech - AT&T Deal will it get through?

CMP : Rs 157
Unitech is one of the Great Multibagger stock in the past. Right now Little bulls are started kicking up in this counter. As AT&T, the US telecom giant, Qatar Telecom and west Asia based telecom major Etisalat are finally shortlisted as the three bidders.

Among the three bidders, AT&T is showing some sort of intrest to enter the Indian telecom market and it is valuving Unitech as a gateway to tap the potential in Indian Markets.AT&T has recently walked out of negotiations with Aircel Ltd,which is now owned by Malaysian telco Maxis.
AT&T is also in talks with Videocon. It shows that AT&T's strong interest to enter Indian Markets.

Unitech is looking to divest between 26-30 per cent in its telecom venture, which may bring in about $800 million to $1 billion valuing the telecom business at $2.5-$3 billion.

But getting this deal done is a heavy task as foreign telcos may find it difficult to agree to many of the terms being put forward by Unitech.Right Now the Stock is Trading at 157 looks a valuable buy at this time. If this deal got confirmed then Unitech might be a turn around story from all its worries.

Core Projects & Technologies Ltd

Scripscan: Core Projects & Technologies Ltd
Cmp:180
Traded in:Nse-Bse

Introduction:Core Projects and Technologies (CPTL) is an IT company with focus on verticals like education, logistics, BFSI, ERP and healthcare.Now why i like the counter:-

1)The company is expected to set up 40 IGNOU centers by FY09 and another 100 by FY10.It also plans to set up another 100 IGNOU centers every year for next 5 years.Core projects is expected to earn Rs 3 crore as one-time income for installation per centre and Rs 2.8 crore per year per centre as recurring income depending on the usage per hour.The development should catapult core projects into a unique league post 2009.

2)Real estate plays had a dream run post 2005 and players like unitech and several others made fortune for lot of people.At that point of time we had few listed scrips and that fuelled the rally.At some point of time i expect the same to happen in these educational plays.Hardly 4-5 companies available with stunning growth prospects.Core projects is one of the great plays which i feel everyone should opt in their core portfolio.

3)The company has also tied-up with IL&FS–ETS to offer comprehensive IT solutions in the education programmes under space.The JV is targeted at state governments that are initiating various education SSA.The JV expects to earn approximately Rs 1,000 per year/child as a typical state has about 8 million students.Hence, the project could result in potential revenue of Rs 800 crore each year for the next 5 years.The JV could earn a fat 120crs revenue per year.

4)IT spend in the education sector is expected to increase to US $62 billion by 2010. An end-to-end solution provider with three recent acquisitions,The company is becoming a major player in the global IT education space.The company currently has more than 30 products in the education space with clients in the US, UK, Africa and Nigeria.

Conclusion:-The company is expected to become a 1000crs company these year with Np expected to be around 165crs.Core projects is moving up the value chain from a pure IT player to an ITeducation-infrastructure company.Core projects is quoting at less than 10 times its fy09 earnings.The company is all set to get rerated in the bourses. We expect the counter to outperform markets in a major way.

Indiabulls retail-potential multibagger

Scripscan:Piramyd Retail Ltd(indiabulls retail)
Cmp:70
Traded in:Nse-bse.

Why Indiabulls retail can give huge returns going forward:-

1) Pitamyd retails (Now Indiabulls retail) is a lifestyle retail and convenience store chain with over 42 stores spread over more than 10 lakh square feet, operating under the Piramyd Megastore and Trumart brands. The company has been recently acquired by the indiabulls group and its retail plans include an investment of Rs1,500 crore to build 30 hypermarkets over the next 15-18 months.

2)Major advantage of piramyd retail stems from the fact that indiabulls has huge real estate advantage on its side thus hedging out land supply and rentals which has off late become a major cost to the retailers.Indiabulls has also got broking and consumer finance divisions and they plan to acquire several clients through piramyd retails stores making a win-win situation for both the company.

3)Few years ago, Piramyd retail was seen as a strong competitor to players such as Shopper's Stop and pantaloon retail. However, an unclear growth vision saw the company slipping even as the competition picked up steam in recent years and it failed to cash in effectively on the first-mover advantage.With indiabulls behind now the company may just get considered among the leaders over the next few years.

Logic:-Indiabulls since its ipo over the last 4 years has been a 50 bagger.Whatever the group touched transformed into gold.You name it brokerage,real estate,consumer finance.Now it plans to be the leader in the retail sector.With the dynamic and aggresive management am sure they would be able to satiate the desires.

Conclusion:-The Indian retail industry in valued at about $300 billion and is expected to grow to $427 billion in 2010 and $637 billion in 2015.The Indian retailing sector is at an inflexion point where the growth of organised retail and growth in the consumption by Indians is going to adopt a higher growth trajectory. The Indian population is witnessing a significant change in its demographics.A large young working population with median age of 24 years, nuclear families in urban areas, along with increasing working-women population and emerging opportunities in the services sector are going to be the key growth drivers of the organised retail sector.The company hopes to capitalise on the huge oppurtuinty and it aims to catapult itself in the top league.Now,Piramyd retail is not a valuation play.Its a play on hope,prospects and pedigree vision.So if you feel you havent got a retail pie in your bag,piramyd may well suit you the best.

News/Multibagger Recommendations/Tips - 23rd July


Stocks News & Views



Multibagger Small Cap Stocks
Huge targets are being assigned for all the stocks listed below. Each of the company has been in news and have been discussed as multibagger in future. Checkout These Stocks…


Bull Market Is Over - Ramesh Damani
On whether history has taught us anything about the bull market and whether we can expect to retrace those hisoon, Ramesh Damani, member of BSE feels that for Nifty, 5000 levels is the line in the sand. Read On.......


Vishal Information Technologies - IPO Analysis
Given its growth prospects and sound management, investors with a two-year horizon can consider Vishal Information Technologies' IPO
Read Complete Analysis


Research Reports - ABC Bearings Ltd. & Excel Crop Care Ltd.
Click Here To Read


Value / Multibagger Stocks

Good Long Term Investment Stock Picks in Current Market

It is very strongly advisable for long term investors to BUY the following Scrips at current price for long term investment. Read On....


Jubilant Organosys - Long term investment pick

Attractive valuations and growth potential make it a good bet for long-term investors, who want to cash in on fast-track growth in the CRAMS segment      Read The Report



*** Visit re-launched Stocks News & Views for more research reports and recent stock recommendations ***

 

Multibagger Small Cap stocks

Huge targets are being assigned for all the stocks listed below. Each of the company has been in news and have been discussed as multibagger in future. Checkout… Confirm from your study/research and please update here thru comments for other's benefit… ….

1)India foils:The company has been taken over by the ess dee aluminium group.Lot of sub-orders got passed to the company from the new parent and restructuring is in its full course of action.The scrip is set to come out of the BIFR and spring a suprise in its quarterley numbers.Market man expects huge upsides from the present level of 13-14rs.They says lot of "hot news" are set to pour in for the counter.

2)Novopan Industries Ltd: A guy from geojit is very bullish on it.He has a confirm news of some "RJ" buying a lot of stake in the counter.Now the company geojit has got a large shareholder named "RJ".So it can very well be another case of front running,so if the same vindicates one can certainly make a lot of money.The company is presently quoting at 30 odd rs.

3)Super Syncotex (India) Ltd: An young operator from mumbai who has acquired a chunk of these company feels the next multibagger has been already made a part of his portfolio.He attributes the reason to the management change that super synco recently had.I am not sure about the news but he has been instantneous in his approach to garner the major pie.The scrip is availabe at 2rs now.

4)Span Diagnostics Ltd: An experienced market expert feel span diagnostics is one of the better scrips to opt for in these sort of market uncertainity.The company is set to come up with some blockbuster announcements which would double the stock price.He adds by saying,"span has a tiny equity and very low floating stock-So to take full advantage get it now or else theres always a slip between the cup and the lip.Its cmp is just 60 now.

5)Avon Organics Ltd: A group of people have taken lot of positions in avon organics.They says the company has alredy started showings of worst being over and has delivered stupendous numbers.The same trend is expected to contine if not better.The scrip has a decent book value and these people expects avon to perform much betterly in the coming days.At 16-17rs avon is a steal-they concludes.

Jubilant Organosys-good stock for long-term investors

Attractive valuations and growth potential make it a good bet for long-term investors, who want to cash in on fast-track growth in the CRAMS segment

IN THE current environment of cost-cutting, outsourcing has gained prominence. In the pharmaceutical sector, this is represented by contract research and manufacturing services (CRAMS) business, which has huge growth potential. Jubilant Organosys has become the largest player in the CRAMS segment, after the recent acquisition of US firm Draxis. The company's attractive valuations and growth potential make it an interesting bet for long-term investors.

BUSINESS:

Established in 1978, the Uttar Pradesh-based company was formerly known as Vam Organic Chemicals (VOCL) and was promoted by Sweden-based Bofors, Hindustan Wires and ML Bhartia of the Bhartia group. Over the years, Jubilant has evolved into an integrated pharma player, while continuing its legacy business of industrial chemicals. The company was one of the first in India to venture into the CRAMS segment, providing products and services to global life sciences companies. It is currently involved in contract research and manufacturing of active pharma ingredients (APIs) and industrial chemicals.

   The company has four different business divisions, viz pharma and life science products (PLSP), drug discovery and development services (DDDS), industrial products and performance polymers. Jubilant earns 63% of its revenue from the pharma business and the remaining from its industrial and performance products. More than 70% of its revenue is contributed by its international business, while the rest is accounted for by its domestic business.
   The company has also forayed into the healthcare segment and currently operates a 92-bed hospital in West Bengal. This is a strategic move towards forward integration, as it will help the company to enroll patients for its growing clinical trial services.

GROWTH STRATEGY:

Jubilant's pharma and drug discovery businesses are expected to record the fastest growth, going forward. The ratio of the company's pharma to non-pharma business is likely to increase to 75:25 within the next few years. In June '07, Jubilant acquired US-based Hollister-Stier Labs, operating in the contract injectibles segment. In May '08, the company acquired Speciality Molecules, a niche manufacturer of speciality intermediates, with manufacturing facilities located in Mumbai, for Rs 20 crore. The acquisition strengthened Jubilant's ability to provide comprehensive pyridine derivatives to customers in the life sciences industry. Around the same time, it acquired Canada-based Draxis for $253 million, marking its entry into the $750-million US radiopharmaceutical market and increasing its business of sterile and non
sterile products in the US.
   This month, the company's 100% subsidiary, Jubilant Biosys, entered into a drug discovery partnership with Amgen, the largest US-based biotech company. Under this partnership, Amgen and Jubilant will collaborate to develop a portfolio of novel drugs in new target areas of interest across multiple therapeutic areas. The company plans to ramp up its hub & spokes hospital business to a 1,000-bed hospital with a capital expenditure (capex) of Rs 170-180 crore by '10. This will significantly boosts its revenues in future.

FINANCIALS:

Over the past five fiscal years, Jubilant has posted a compound annual growth rate (CAGR) of 25.5% in consolidated revenues, which stood at Rs 2,488.9 crore in FY08. Likewise, the company's consolidated earnings have witnessed a CAGR of 53% during the same period to reach Rs 400.5 crore
in FY08. However, since the company is in a growth phase, it has a low dividend payout ratio of 12% (average of past five years) and hence, a lower dividend yield.
   The company has adopted the strategy of growing inorganically. But going forward, it plans to grow organically and integrate its acquired businesses. For this, Jubilant plans to incur a capex of Rs 700 crore during FY09.

VALUATIONS:

The company is currently trading at an earnings per share (EPS) of Rs 18.3. Due to expansion in capacities, increased product profile and expanding global market footprint, it expects to post more than 50% increase in revenue for FY09. Accordingly, considering
Jubilant's estimated consolidated earnings for FY09 and FY10, the company is currently trading at forward P/Es of 8.5 and 6.3, respectively.
   Jubilant's stock has outperformed the Sensex since the beginning of this year. Its stock price has declined only 8.6%, against 35% fall registered by the Sensex. Investors who want to cash in on the fast-track growth in the CRAMS segment can consider this undervalued stock.

Beta: 0.4
Institutional Holding: 32%
Dividend Yield: 0.4%
P/E: 17.4
M-Cap: Rs 4,702.1 cr
CMP: Rs 319

Source: Economic Times

Bull Market Over - Ramesh Damani

On whether history has taught us anything about the bull market and whether we can expect to retrace those highs soon, Ramesh Damani, member of BSE feels that for Nifty, 5000 levels is the line in the sand. He said, "If we cross and if the circumstances change, then we will have to revisit the bear case and say that maybe our strategies and studies are wrong and maybe the world has changed. It's not doomsday, it's just a sharp correction in a bull market."
Damani feels the bull market has ended and will not resume very soon. According to him, the macro economic environment has changed and the indices may not cross the old highs again in 2008. He feels that crude oil prices will be the key to market trend and there will be more pain if rally in crude oil resumes. According to him, it is unlikely to go back to the oil highs for one-two years and Nifty may not cross 4500-5000 if crude remains high.

He believes that it is a great time to pick individual stocks for long-term. The global bull market on easy liquidity flows is over and bond yields are negative due to high inflation level, he said. According to him, equity market is the best hedge in countries like India. He said that the best case bear market rally would take Nifty to 5000 and markets will revisit bear case if Nifty rallies above 5000 levels.

Going back to the history, Damani said that the one thing that history teaches us is that greater the bull market and the ferocity of the bull market, the more time it takes to come back to its old high. He believes that this has been a ferocious bull market in all accounts. A lot of wealth, market capital has been generated and the correction will be painful, he said. He feels that now at every rise there will be sellers who will be stuck and will want to come and sell, so that churning process takes time. So given the ferocity of the bull market, it will take more than a normal bull market to sort this out.

He said, "The key to the riddle of the markets, whether it's bottomed out or it's going to be bottomed out is the price of oil. It's one of the most significant events of our lifetime and if you make the case that crude at the start of the correction will slip to below 100-120, then you can see the process of bottoming out. If you are going to make the case that this is a temporary correction and that the bull market in crude is still alive then going back to plus-USD 150 per barrel can bring a lot more pain in the markets."
Source: Moneycontrol

Vishal Information Technologies - IPO Analysis

Given its growth prospects and sound management, investors with a two-year horizon can consider Vishal Information Technologies’ IPO
COMPANY: VISHAL INFORMATION TECHNOLOGIES
ISSUE SIZE: Rs 39.1-41.9 CRORE
PRICE BAND: Rs 140-150
DATE: JULY 21-24, ’08

CHENNAI-BASED non-voice BPO service provider, Vishal Information Technologies (VITL), is hitting the primary market to fund its expansion plans, including setting up a bigger campus and marketing offices in the US and UK.
Out of 27,90,000 shares that will be offered to the public, 17,90,000 are fresh, while the rest will be offloaded by the existing promoters. Post-listing, the promoters’ stake will decline to 42.9%from 51.5%.

BUSINESS:
The Rs 41-crore VITL is a subsidiary of Tutis Technologies. VITL provides IT-enabled services (ITeS) in the areas of data digitisation, e-publishing and digital library. These services fall under the non-voice category of the ITeS segment. VITL has a subsidiary called Basiz Fund Accounting Services, in which it holds 86.9% stake. Basiz provides sub-fund accounting and administration services to hedge funds, private equity firms, mutual funds and insurance companies in various countries including the US, UK, Hong Kong and Singapore.

VITL derives more than 98% of its revenue from overseas clients. The UK is the company’s biggest market, contributing three-fourths to its total revenue. Among its three verticals, data archiving accounts for 60% of its topline, while epublishing contributes 30%. The rest comes from Basiz. Though Basiz contributes to just over 10% of VTIL’s business, it provides a much better operating margin of 45%, compared to 25-30% for other verticals. Revenues from services, including archiving and e-publishing, are project-based and hence, lumpy in nature. To reduce its exposure to this lumpiness, VTIL is focusing its attention on print-on-demand (POD) and digital library services. These services are recurring in nature and hence, provide higher revenue visibility.

FINANCIALS:
VTIL’s topline and bottomline have shown a compound annual growth rate (CAGR) of 31% over a period of four years ended March ’08. Along with a sustained growth rate in sales and profit, the company has also maintained healthy margins. Its operating margin improved from 32% in FY04 to 36% in FY08. Its net margin has more or less remained flat at 30% during this period. However, compared to FY07, its net margin shrank by 220 basis points due to the imposition of minimum alternative tax (MAT) on IT companies.

VALUATIONS:
On a post-issue basis, the company is asking for a valuation of over 13 times its FY08 earnings, considering the upper side of its price band. This is rather high compared to the price-earnings (P/E) multiple of 7-9 for companies such as Datamatics Technologies and Tricom, which provide digitisation services. The higher valuation of VTIL can be attributed to its stable financial performance and future prospects.

The company is working on a pilot project with Royal National Institute for the Blind (RNIB), UK, to provide digital library services. Further, it has tied up with leading book publishers in the UK and US for POD services. These two new lines of businesses, along with existing ones, are expected to maintain the company’s growth momentum. Investors with a two-year horizon can consider this IPO.

Bull's Eye Stocks-BAJAJ HINDUSTHAN,INDIABULLS REAL ESTATE,RELIANCE,AXIS BANK,PUNJAB NATIONAL BANK

BAJAJ HINDUSTHAN
RESEARCH: MERRILL LYNCH
RATING: UNDERPERFORM
CMP: RS 144
MERRILL Lynch has maintained the ‘underperform’ rating on Bajaj Hindusthan, with a reduced target price of Rs 136. It expects the company to be impacted by higher cane prices, following the recent High Court approval for a government-determined price in Uttar Pradesh (UP). The decline in target price is driven by 23% cut in FY09E EPS and lower target P/E of 11.8x at a 10% discount to the sector average. The possibility of an increase in cane costs and likely decline in cane availability are key reasons for the stock’s underperform rating. Merrill Lynch has cut its gross margin assumption on account of higher cane costs and lowerthan-expected production. On July 7, ’08, the UP High Court upheld the power of the government to fix sugarcane prices in its dispute with sugar mills. The government has asked UP-based sugar mills, including Bajaj Hindusthan, to pay Rs 1,250 per tonne of normal variety of sugarcane, compared to Rs 1,100/tonne decided earlier, as per an interim order in FY08. This is higher than Merrill Lynch’s assumption and is set to rise further as the cost of production, the key determinant of price, increases. While the UP High Court has given its final verdict, the Supreme Court’s decision is awaited. Merrill Lynch now assumes a sugarcane cost of Rs 1,350/tonne in FY09. At Rs 1,100/tonne cane price, Merrill Lynch’s FY09E EPS will rise by 101%. However, cane costs will rise, irrespective of SC’s decision, as the cost of cane production has increased to Rs 1,141/tonne for FY08, as estimated by the UP Cane Research Farm.

INDIABULLS REAL ESTATE
RESEARCH: CREDIT SUISSE
RATING: NEUTRAL
CMP: RS 290
CREDIT Suisse has upgraded its rating on Indiabulls Real Estate (IBREL) to ‘neutral’ from ‘underperform’ on valuation grounds. The new target price of Rs 308 is based on a 40% discount to the FY09E net asset value (NAV). In a deteriorating macro environment, real estate developers are seeing slowing demand for both residential and commercial projects, which, coupled with difficulties in fund-raising from other sources, may lead to delays in launches. IBREL’s Jupiter and Elphinstone Mill projects and cash invested in other businesses boost its valuation. Further, IBREL has a potential development of 5,447 mw power capacity, which can act as a catalyst for the stock in future. Credit Suisse’s FY09E NAV for IBREL stands reduced to Rs 353 from Rs 447. The company’s Jupiter and Elphinstone Mill projects are nearing completion, and account for Rs 126/share in the valuation, even when valued at a conservative cap rate of 10.5%. These, coupled with net cash of Rs 65 per share, lend comfort to the valuation, as they account for ~70% of IBREL’s current market price of Rs 273. Credit Suisse has revised its estimates for IBREL to account for slower launches, and hiked its weighted average cost of capital (WACC) and cap rate assumptions to factor in a worsening macro environment. Credit Suisse has now assumed a WACC of 14.85% for IBREL (13.3% earlier), on a higher risk-free rate assumption of 9.5% (8.2% earlier), and higher cap rates of 10.5% and 12% (9% and 10% earlier) for commercial and retail lease projects, respectively. Accordingly, the FY09E NAV for IBREL stands reduced to Rs 353 from Rs 447.

RELIANCE INDUSTRIES
RESEARCH: CLSA
RATING: OUTPERFORM
CMP: RS 2,113
A BOUT of negative news flow across businesses has weighed on Reliance Industries (RIL) recently. Cumulatively, these risks can shave off 33% from its FY10 EPS and 28% from its fair value estimate. While some of these risks may materialise, most are transitory and are likely to subside. The finance ministry is said to be seriously considering a cut in petrochemical tariffs, given the spike in inflation. Demand for imposition of windfall tax and withdrawal of EOU benefit for RIL’s refinery have gained currency in recent weeks. The RPET and KG-D6 gas projects have also slipped past initial expectations. Further, the uncertainty on Section 80-IB income tax benefits continues, while the Reliance-RNRL court case is still dragging on. The estimates of an October ’08 start-up for RPET and KG-D6 gas do not appear at risk currently, but they cannot be ruled out — especially for the KG-D6 gas project, which RIL has indicated is running four months behind its June ’08 internal target. The company’s FY09 earnings will depend on the timing of project start-up, but overall, CLSA sees limited fair value risk from these uncertainties. Further, with the worse-case scenario (Rs 1,845/share) being only 9% lower, downsides appear limited, even if these uncertainties remain. RIL’s valuation multiples (9x P/E, 6.8x P/CF, 47% EPS CAGR) are now 15% lower than the Sensex on FY10 estimates and in a ±5% range to its global peers (9.6x P/E, 6.8x P/CF).

AXIS BANK
RESEARCH: HSBC
RATING: NEUTRAL
CMP: RS 687
AXIS Bank’s Q1 FY09 net profit was Rs 330 crore (+89% y-o-y), significantly above the estimates of Rs 225 crore. The company’s earnings drivers remain strong, in line with estimates, with net interest income up 81% y-o-y and non-interest income up 83% y-o-y. Net interest margin was 3.35%, down 60 bps q-o-q on high cost of funds. A striking feature of the bank’s result was the 194% y-o-y increase in provisions and contingencies. Provisions for investment depreciation rose 339% y-o-y, while loan loss provision rose 44% y-o-y. The sharp rise in the former is due to the steep increase in G-Sec yields, to 9.31%. Asset quality deteriorated, with net NPLs rising to 0.47%, versus 0.36% as of end-March ’08. Effects of a slowdown in the sector and lag effects of monetary tightening were reflected in Axis Bank’s credit offtake, which moderated to 48% as of end-June ’08, from 62% as of end-March ’08. The SME and mid-corporate segments are still driving growth. HSBC lowers its loan growth estimates and increases its estimates for credit costs for FY09-11E. It now assumes a 9.5% cost of equity, compared to 7.5% earlier, in view of the deteriorating macro economic environment. Increase in provisions for credit costs and MTM losses on the bond portfolio are key risks.

PUNJAB NATIONAL BANK
RESEARCH: INDIABULLS SECURITIES
RATING: BUY
CMP: RS 440
PUNJAB National Bank (PNB) saw improvement across many fronts in Q4 FY08. Its net interest income (NII) rose 12.7% y-o-y in Q4, compared to less than 5% growth in both Q2 and Q3. Better asset quality led to a substantial fall in provisioning, which boosted the bank’s bottomline. Indiabulls Securities maintains ‘buy’ rating on the stock due to the following reasons: The bank’s net interest margin (NIM), at 3.66%, is one of the highest in the industry. Moving forward, NIM is likely to be sustained at these levels, as PNB recently increased its PLR by 50 bps, while it hiked deposit rates by 25-50 bps. Further, the re-pricing of high-cost deposits by the bank in Q4 will help it to maintain the cost of funds. PNB’s large rural presence helps it to mobilise low-cost deposits. This helps to keep its CASA ratio among the highest in the industry (43% in Q4). There has been a decline in the bank’s NPA ratio, both on a yearly and sequential base, to 0.64%. On a sequential basis, NPAs fell by 69 bps due to the upgradation of technical NPAs, while they declined by 12 bps on a yearly basis. This reflects that PNB has improved its recovery efforts and risk management practices, which will help it to maintain its asset quality in the current high interest rate scenario, as the latter increases the risk of default.

Good long term invetment picks

It is very strongly advisable for long term investors to BUY the following Scrips at current price for Long Term Investments.

1. Gujarat NRE Coke Ltd
2. Chennai Petroleum Corporation Ltd
3. Sasken Communication Technology Ltd
4. Max India Ltd

Some Financial Informations:-

Gujarat NRE Coke Ltd ( Rs. 113.65 ) :
Net profit of Gujarat NRE Coke rose 120.46% to Rs 94.40 crore in the quarter ended June 2008 as against Rs 42.82 crore during the previous quarter ended June 2007. Sales rose 153.64% to Rs 377.64 crore in the quarter ended June 2008 as against Rs 148.89 crore during the previous quarter ended June 2007

Chennai Petroleum Corporation Ltd ( CMP Rs. 304.95 ) :
Net profit of Chennai Petroleum Corporation rose 117.63% to Rs 703.27 crore in the quarter ended June 2008 as against Rs 323.15 crore during the previous quarter ended June 2007. Sales rose 77.10% to Rs 11151.10 crore in the quarter ended June 2008 as against Rs 6296.61 crore during the previous quarter ended June 2007.

Sasken Communication Technology Ltd ( CMP Rs. 139.45 ) :
Net profit of Sasken Communication Technology rose 389.30% to Rs 9.15 crore in the quarter ended June 2008 as against Rs 1.87 crore during the previous quarter ended June 2007. Sales rose 25.31% to Rs 110.72 crore in the quarter ended June 2008 as against Rs 88.36 crore during the previous quarter ended June 2007.
Read: Sasken Communications:Buy recommendation

Max India Ltd ( CMP Rs. 154.80 ) :
Net profit of Max India rose 257.22% to Rs 13.61 crore in the quarter ended June 2008 as against Rs 3.81crore during the previous quarter ended June 2007. Sales rose 89.64% to Rs 91.52 crore in the quarter ended June 2008 as against Rs 48.26 crore during the previous quarter ended June 2007.

ABC Bearings-Excel Crop Care-Research Reports

..
ABC Bearings Limited (ABCL)-Buy Recommendation research report
Report Date: July 18, 2008.
CMP – Rs. 68/-
Target Price – Rs. 100/-
Mkt. Cap. Rs. 78.5 crore
Click Here To Read This Read Report


Excel Crop Care Limited (ECCL)-BUY report
Report Date: July 17, 2008
Recommendation: BUY
CMP – Rs. 135/-
Target Price – Rs. 200/-
Mkt. Cap. - Rs. 148.58 crore Click Here To Read This Report